SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-009673
Filing Date
2019-05-29
Accepted
2019-05-28 17:42:21
Documents
1
Period of Report
2019-05-28

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f6k052819_biondvax.htm 6-K 10032
  Complete submission text file 0001213900-19-009673.txt   11022
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 19858887
SIC: 2836 Biological Products, (No Diagnostic Substances)